MedDataX Logo

Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program

NCT ID: NCT05113667

Last Updated: 2023-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2021-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the impact of clinical pharmacist-led appropriate acid suppression therapy stewardship program in hospitalized older patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Pharmacist-led Discharge Education Service in Acute Coronary Syndrome

NCT05153707

Acute Coronary Syndrome
COMPLETED NA

Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program

NCT03812848

Deep Vein Thrombosis Atrial Fibrillation Mitral Valve Disease
COMPLETED NA

The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients

NCT05168449

Chronic Kidney Diseases Adherence, Medication
COMPLETED NA

:Effects of Pharmaceutical Care in Stroke Patients

NCT06129318

Stroke
COMPLETED NA

The Pharmacist in the Acute Geriatric Inpatient Treatment Team

NCT03412903

Pharmacists in Geriatric Health Services Conditions Unspecified
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective, nonrandomized controlled study was conducted in older patients who ordered proton pump inhibitor (PPI) at admission in an internal medicine service of tertiary training and research hospital. In the intervention group, clinical pharmacist-led services (including medication reconciliation and medication review) were conducted during hospitalization and at discharge by using the guidelines and potentially inappropriate medications (PIM) criteria \[American Geriatric Society-AGS Beers Criteria©, 2019\]. Medication Appropriateness Index (MAI), inappropriate PPI cost, and hospitalization for gastrointestinal bleeding within 1 year after discharge were calculated in both groups

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Geriatric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clinical pharmacist-led services

Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program

Group Type EXPERIMENTAL

Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program

Intervention Type OTHER

Clinical pharmacist provided medication reconciliation and medication review during the hospital stay.

Control group

Usual care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program

Clinical pharmacist provided medication reconciliation and medication review during the hospital stay.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 65 years old or greater
* Admitted to the hospital with any reason
* Ordered at least one PPI dose within 48 hours of admission

Exclusion Criteria

* Transferred to another ward (including an intensive care unit)
* Having active gastrointestinal bleeding
* Having active malignity
Minimum Eligible Age

65 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Marmara University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Betul Okuyan

Assoc.Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Betul Okuyan

Role: PRINCIPAL_INVESTIGATOR

Marmara University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Marmara University

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Dumlu HI, Sancar M, Ozdemir A, Okuyan B. Impact of a clinical pharmacist-led stewardship program for the appropriate use of acid suppression therapy in older hospitalized patients: a non-randomized controlled study. Int J Clin Pharm. 2022 Aug;44(4):914-921. doi: 10.1007/s11096-022-01394-8. Epub 2022 Apr 21.

Reference Type DERIVED
PMID: 35449351 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MUHSI-2019/29-78

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Pharmacist Anticoagulant Stewardship
NCT03527615 UNKNOWN
Clinical Pharmacist Impact Study
NCT07269002 COMPLETED NA
Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments
NCT03827031 RECRUITING NA
Efficacy of Pharmacist Interventions Through the "Medication Therapy Management Pathway in Hypertensive Patients"
NCT06310512 NOT_YET_RECRUITING NA
Evaluation Of Clinical Pharmacy Services in Patients Receiving Antithrombotic Treatment
NCT06193473 COMPLETED NA
Perceptions of Healthcare Professionals Toward Clinical Pharmacy Practice in Egypt
NCT07248150 COMPLETED
Impact of Medication Review by Community Pharmacists
NCT05297461 COMPLETED NA
Optimizing Drug-Therapy in Patients 80 Years and Older
NCT00661310 COMPLETED NA
Medication Safety of Elderly Patients in Hospital and Ambulatory Setting
NCT01578525 COMPLETED NA
Adverse Drug Event Prevention Using Structured Pharmacist Review
NCT01467128 COMPLETED PHASE4
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
NCT06071065 COMPLETED NA
Impact of a Mobile Geriatric Team With a Pharmacist on the Optimisation of Prescriptions in Elderly Inpatients
NCT04151797 COMPLETED NA
A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly
NCT03257605 COMPLETED
Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE
NCT04617340 COMPLETED NA
Cost-benefit Analysis of a Clinical Pharmacist Intervention
NCT03803033 COMPLETED NA
What is the Impact of Implementing Pharmaceutical Algorithms in the PharmaClass® Software, on the Handling the Patient's Medication Load, by the Clinical Pharmacist?
NCT05416892 COMPLETED
Medication Reviews Bridging Healthcare: a Cluster-randomised Crossover Trial
NCT02999412 COMPLETED NA
Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'.
NCT04645836 COMPLETED NA
Impact of Clinical Pharmacy Services Provided for Patients With Active Rheumatoid Arthritis
NCT03743181 COMPLETED
Rationalisation of Polypharmacy in the Elderly by the RASP Instrument
NCT01513265 COMPLETED NA
Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older
NCT02598115 COMPLETED NA
The Impact of Clinical Pharmacist in the Identification and Management of Treatment Related Problems in the Surgery Ward
NCT04941820 COMPLETED NA
Prevention of Potentially Inappropriate Prescribing in Late Life Using Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) and Screening Tool to Alert Doctors to Right Treatment (START) Criteria
NCT00915824 UNKNOWN PHASE4
Impact of the Intervention of Pharmacists and Geriatrician on Drug Prescription in Elderly Patients in a Surgical ICU
NCT03706092 COMPLETED
The Impact of Clinical Pharmacists Role in Transition of Care From Other Departments to Critical Care Units in Alexandria Main University Hospital.
NCT06903572 COMPLETED NA